ISRCTN33957677
Completed
N/A
A pilot study to examine the safety and efficacy of posterior juxta-scleral (80 mg) triamcinolone acetonide, administration, in addition to Visudyne (verteporfin) photodynamic therapy for predominantly classic choroidal neovascularisation secondary to age-related macular degeneration: an open-label, randomised, active controlled trial
King's College Hospital (UK)0 sites80 target enrollmentJanuary 18, 2008
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- King's College Hospital (UK)
- Enrollment
- 80
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Age 50 years or older, male and female
- •2\. Clinical diagnosis of age\-related macular degeneration (AMD)
- •3\. Subfoveal choroidal neovascularisation (CNV) confirmed by fluorescein angiography
- •4\. Best corrected visual acuity of 35 letters on Early Treatment Diabetic Retinopathy Study (ETDRS) chart
Exclusion Criteria
- •1\. Inability to understand or sign consent form
- •2\. The patient has a current medical condition or history of a medical condition that would be likely to preclude scheduled study visits
- •3\. Patient has a current ophthalmic condition or history of an ophthalmic condition that might compromise the assessment of the treatment
- •4\. Signs of a myopic retina or refraction of greater than \-8 dioptres in their current or previous glasses prescription
- •5\. Signs of other retinal conditions that may have caused the CNV such as angioid streaks, choroidal rupture, and old chorio\-retinitis
- •6\. Open angle glaucoma
- •7\. At increased risk of developing glaucoma such as having; pigment dispersion syndrome or pseudoexfoliation
- •8\. Unable to have a good quality fluorescein angiogram taken, e.g., due to head tremor or media opacity
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Combination therapy of Visudyne, Minocycline, Dexamethasone and Ranibizumab (VIMDER) for the treatment of subfoveal choroidal neovascularisation (CNV)ISRCTN34410935King's College Hospital NHS Foundation Trust (UK)20
Active, Not Recruiting
N/A
A pilot study to examine the efficacy and safety of escitalopram in doses up to 50 mg for the treatment of patients with Major Depressive Disorder (MDD). - Resistant Depression StudyMajor Depressive DisorderMedDRA version: 9.1Level: LLTClassification code 10025453Term: Major depressive disorder NOSEUCTR2008-003359-58-GBCPS Research60
Completed
Phase 2
A pilot study to explore the efficacy and safety of jam oral immunotherapy with hypoallergenized cow's milk for children with cow's milk allergyfood allergy (cow's milk)JPRN-UMIN000018372ational Center for Child Health and Development10
Recruiting
Phase 2
Pilot cml autograft/glivec (STI571)/Intron A trialAdvanced phase chronic myeloid leukaemiaPh-positive acute lymphoblastic leukemiaCancer - Leukaemia - Acute leukaemiaACTRN12605000071628Australasian Leukaemia and Lymphoma Group48
Completed
N/A
Safety and efficacy of Transcend CyPass glaucoma implant in open angle glaucoma patients who have failed medical treatmentPrimary open angle glaucomaEye DiseasesGlaucomaISRCTN23263504Transcend Medical, Inc.™ (USA)20